
  
    
      
        Background_NNP
        Mutations_NNP in_IN Bruton_NNP 's_POS tyrosine_NN kinase_NN (_( Btk_NNP )_) are_VBP
        responsible_JJ for_IN the_DT human_JJ disease_NN termed_VBD X-_NNP linked_VBD
        agammaglobulinemia_NN (_( XLA_NNP )_) (_( reviewed_VBN in_IN reference_NN [_NN 1_CD ]_NN )_) ._. The_DT
        B_NNP cell_NN antigen_NN receptor_NN (_( BCR_NNP )_) signaling_VBG defect_NN is_VBZ very_RB
        severe_JJ such_JJ that_IN XLA_NNP patients_NNS have_VBP a_DT block_NN in_IN the_DT pro-_JJ B_NNP to_TO
        pre-_NN B_NNP cell_NN transition_NN and_CC consequently_RB have_VBP no_DT mature_VBP B_NNP
        cells_NNS ._. The_DT 
        xid_NN mouse_NN ,_, in_IN which_WDT Btk_NNP is_VBZ mutated_VBN ,_,
        and_CC the_DT Btk_NNP knockout_NN mouse_NN display_NN similar_JJ ,_, although_IN
        somewhat_RB less_RBR severe_JJ ,_, phenotypes_NNS [_NN 1_CD ]_NN ._. Btk_NNP is_VBZ the_DT
        prototypical_JJ member_NN of_IN the_DT Tec_NNP family_NN of_IN non-receptor_JJ
        protein_NN tyrosine_NN kinases_NNS (_( PTKs_NNP )_) that_WDT includes_VBZ Bmx_NNP ,_, Itk_NNP ,_, Tec_NNP
        and_CC Txk_NNP [_NN 2_CD ,_, 3_CD ]_NN ._. In_IN addition_NN to_TO a_DT COOH-terminal_NNP PTK_NNP domain_NN ,_,
        Btk_NNP has_VBZ an_DT NH_NNP 
        2_CD -_: terminal_NN pleckstrin_NN homology_NN (_( PH_NNP )_)
        domain_NN ,_, a_DT proline-rich_JJ Tec_NNP homology_NN domain_NN ,_, a_DT Src-homology_NNP
        3_CD (_( SH_NNP 3_LS )_) domain_NN and_CC a_DT Src-homology_NNP 2_CD (_( SH_NNP 2_LS )_) domain_NN ._. Btk_NNP was_VBD
        originally_RB identified_VBN in_IN B_NNP cells_NNS but_CC is_VBZ now_RB known_VBN to_TO be_VB
        expressed_VBN in_IN most_JJS leukocytes_NNS with_IN the_DT exception_NN of_IN T_NN cells_NNS
        and_CC NK_NNP cells_NNS ._.
        Btk_NNP is_VBZ thought_VBN to_TO be_VB activated_VBN upon_IN BCR_NNP cross-linking_JJ by_IN
        a_DT two-step_JJ mechanism_NN involving_VBG phosphatidylinositol_NN (_( PI_NNP )_)
        3_CD -_: kinase_NN and_CC the_DT Src_NNP family_NN PTK_NNP Lyn_NNP (_( reviewed_VBN in_IN references_NNS
        [_NN 4_CD ,_, 5_CD ,_, 6_CD ]_NN )_) ._. PI_NNP 3_CD -_: kinase_NN induces_VBZ Btk_NNP membrane_NN targeting_VBG by_IN
        generating_VBG phosphatidylinositol_NN 3_CD ,_, 4_CD ,_, 5_CD -_: trisphosphate_NN (_( PIP_NNP 3_LS )_)
        to_TO which_WDT the_DT PH_NNP domain_NN of_IN Btk_NNP binds_NNS ._. Lyn_NNP
        transphosphorylates_NNS Btk_NNP within_IN the_DT activation_NN loop_NN of_IN the_DT
        kinase_NN domain_NN ,_, allowing_VBG subsequent_JJ autophosphorylation_NN of_IN
        the_DT Btk_NNP SH_NNP 3_CD domain_NN and_CC full_JJ Btk_NNP activation_NN ._. The_DT SH_NNP 2_CD
        domain-containing_JJ inositol_NN phosphatase_NN (_( SHIP_NNP )_) downregulates_NNS
        Btk_NNP by_IN dephosphorylating_VBG PIP_NNP 3_CD [_NN 4_CD ,_, 5_CD ,_, 6_CD ]_NN ._.
        Biochemical_NNP studies_NNS of_IN Btk-deficient_NNP B_NNP cells_NNS have_VBP shown_VBN
        Btk_NNP to_TO be_VB necessary_JJ for_IN BCR-induced_NNP phospholipase_NN C-_NNP γ_NN 2_CD
        (_( PLCγ_NNP 2_LS )_) phosphorylation_NN ,_, calcium_NN mobilization_NN ,_,
        extracellular_NN signal-regulated_JJ kinase_NN (_( ERK_NNP )_) and_CC c-_NN Jun_NNP NH_NNP 
        2_CD -_: terminal_NN kinase_NN (_( JNK_NNP )_)
        mitogen-activated_JJ protein_NN kinase_NN (_( MAPK_NNP )_) activation_NN ,_, NF-κB_NNP
        activation_NN and_CC apoptosis_NNS [_NN 7_CD ,_, 8_CD ,_, 9_CD ,_, 10_CD ,_, 11_CD ,_, 12_CD ]_NN ._. These_DT
        signaling_VBG events_NNS are_VBP generally_RB not_RB entirely_RB abrogated_JJ and_CC
        kinetic_JJ analyses_NNS have_VBP revealed_VBN that_IN the_DT sustained_VBN phases_NNS
        are_VBP particularly_RB impaired_VBN in_IN the_DT absence_NN of_IN Btk_NNP [_NN 8_CD ,_, 9_CD ,_,
        13_CD ]_NN ._. In_IN contrast_NN ,_, these_DT pathways_NNS are_VBP completely_RB inhibited_VBD
        in_IN the_DT absence_NN of_IN the_DT Syk_NNP /_NN ZAP-_NNP 70_CD family_NN tyrosine_NN kinase_NN Syk_NNP
        [_NN 14_CD ]_NN ._. These_DT data_NNS have_VBP led_VBN to_TO the_DT hypothesis_NNS that_IN Btk_NNP
        co-operates_JJ with_IN Syk_NNP in_IN PLCγ_NNP 2_CD -_: dependent_JJ BCR_NNP signaling_VBG and_CC
        that_IN Btk_NNP functions_NNS as_IN a_DT signal_NN duration_NN modulator_NN (_( reviewed_VBN
        in_IN references_NNS [_NN 15_CD ,_, 16_CD ]_NN )_) ._. However_RB ,_, it_PRP is_VBZ not_RB clear_JJ if_IN Btk_NNP
        alone_RB is_VBZ sufficient_JJ to_TO mimic_VB aspects_NNS of_IN BCR_NNP signaling_VBG ,_, nor_CC
        is_VBZ it_PRP known_VBN whether_IN all_DT downstream_JJ signals_NNS mediated_JJ by_IN Btk_NNP
        are_VBP PLCγ_NNP 2_CD -_: dependent_JJ ._. Indeed_RB ,_, additional_JJ functions_NNS for_IN Btk_NNP
        have_VBP recently_RB been_VBN proposed_VBN ,_, namely_RB in_IN PI_NNP 3_CD -_: kinase_NN
        activation_NN [_NN 17_CD ]_NN ,_, cytoskeletal_NN reorganization_NN [_NN 18_CD ]_NN and_CC DNA_NNP
        transcription_NN [_NN 19_CD ,_, 20_CD ,_, 21_CD ]_NN ._.
        In_IN this_DT study_NN we_PRP have_VBP generated_VBN a_DT conditional_JJ form_NN of_IN
        Btk_NNP by_IN fusing_NN the_DT full_JJ length_NN Btk_NNP protein_NN with_IN the_DT
        hormone-binding_JJ domain_NN of_IN the_DT estrogen_NN receptor_NN (_( Btk_NNP :_: ER_NNP )_) ._.
        We_PRP show_VBP that_IN Btk_NNP :_: ER_NNP activation_NN alone_RB is_VBZ sufficient_JJ to_TO
        activate_VBP multiple_JJ downstream_JJ signaling_VBG pathways_NNS in_IN B_NNP cells_NNS ,_,
        including_VBG calcium_NN mobilization_NN ,_, ERK_NNP and_CC JNK_NNP MAPK_NNP ,_, and_CC
        apoptosis_NNS ._. Moreover_RB ,_, by_IN analysing_VBG Btk_NNP :_: ER_NNP function_NN in_IN
        PLCγ_NNP 2_CD -_: deficient_NN cells_NNS ,_, we_PRP show_VBP that_IN PLCγ_NNP 2_CD is_VBZ necessary_JJ for_IN
        Btk_NNP :_: ER_NNP to_TO transmit_VB these_DT signals_NNS ._.
      
      
        Results_NNS and_CC Discussion_NNP
        
          Construction_NNP of_IN Btk_NNP :_: ER_NNP ,_, a_DT conditional_JJ form_NN of_IN
          Btk_NNP
          In_IN order_NN to_TO determine_VB whether_IN Btk_NNP activation_NN alone_RB is_VBZ
          sufficient_JJ to_TO mimic_VB aspects_NNS of_IN BCR_NNP signaling_VBG ,_, we_PRP have_VBP
          generated_VBN Btk_NNP :_: ER_NNP ,_, a_DT novel_NN conditional_JJ form_NN of_IN Btk_NNP ._. Btk_NNP :_: ER_NNP
          was_VBD constructed_VBN such_JJ that_IN the_DT hormone-binding_JJ domain_NN of_IN
          the_DT estrogen_NN receptor_NN was_VBD fused_JJ to_TO the_DT COOH-terminus_NNP of_IN
          full_JJ length_NN Btk_NNP (_( Fig_NNP 1_CD A_DT )_) ._. This_DT approach_NN has_VBZ been_VBN
          successful_JJ in_IN producing_VBG conditional_JJ forms_NNS of_IN the_DT Tec_NNP
          family_NN PTK_NNP Bmx_NNP [_NN 22_CD ]_NN ,_, and_CC also_RB the_DT PTKs_NNP v-_NN Src_NNP [_NN 23_CD ]_NN ,_, Hck_NNP
          [_NN 24_CD ]_NN and_CC Abl_NNP [_NN 25_CD ]_NN ,_, the_DT serine_NN /_NN threonine_NN kinases_NNS Raf_NNP [_NN
          26_CD ]_NN and_CC Akt_NNP [_NN 27_CD ]_NN ,_, and_CC the_DT dual_JJ specificity_NN protein_NN
          kinase_NN MEK_NNP 1_CD [_NN 23_CD ]_NN ._. The_DT mechanism_NN of_IN action_NN of_IN ER_NNP fusion_NN
          proteins_NNS is_VBZ not_RB clear_JJ ,_, although_IN it_PRP appears_VBZ that_IN upon_IN
          treatment_NN of_IN cells_NNS with_IN estrogen_NN or_CC an_DT estrogen_NN analogue_NN ,_,
          for_IN example_NN 4_CD -_: hydroxytamoxifen_NN (_( 4_CD -_: HT_NNP )_) ,_, the_DT biological_JJ
          activities_NNS of_IN the_DT proteins_NNS are_VBP induced_VBN ._. This_DT may_MD involve_VB
          ER_NNP domain_NN dimerization_NN and_CC /_NN or_CC selective_JJ stabilization_NN of_IN
          expression_NN within_IN the_DT cell_NN [_NN 26_CD ]_NN ._. The_DT ER_NNP fusion_NN protein_NN
          method_NN has_VBZ been_VBN shown_VBN to_TO accurately_RB identify_VB downstream_JJ
          substrates_NNS and_CC effects_NNS of_IN the_DT above_JJ mentioned_VBN
          kinases_NNS ._.
          Two_CD forms_NNS of_IN Btk_NNP :_: ER_NNP were_VBD generated_VBN ,_, one_CD using_VBG
          wild-type_JJ (_( WT_NNP )_) Btk_NNP and_CC the_DT other_JJ using_VBG a_DT kinase-inactive_JJ
          (_( K_NNP 430_CD E_NNP )_) mutant_JJ of_IN Btk_NNP as_IN a_DT negative_JJ control_NN (_( Fig_NNP 1_CD A_DT )_) ._. The_DT
          Btk_NNP :_: ER_NNP constructs_NNS were_VBD transfected_JJ into_IN Btk-deficient_NNP
          DT_NNP 40_CD chicken_NN B_NNP cells_NNS and_CC stable_JJ clones_NNS were_VBD selected_VBN that_WDT
          expressed_VBD equivalent_NN levels_NNS of_IN Btk_NNP :_: ER_NNP ._. The_DT DT_NNP 40_CD cell_NN
          system_NN was_VBD used_VBN because_IN it_PRP has_VBZ proved_VBN useful_JJ in_IN
          dissecting_VBG B_NNP cell_NN signaling_VBG pathways_NNS through_IN the_DT use_NN of_IN
          gene_NN knockouts_NNS derived_VBN by_IN homologous_RB recombination_NN [_NN 15_CD ]_NN ._.
          Fig_NNP 1_CD Bshows_NNP that_IN WT_NNP Btk_NNP :_: ER_NNP was_VBD kinase_NN active_JJ 
          in_IN vitro_NN as_IN determined_VBN by_IN
          autophosphorylation_NN and_CC phosphorylation_NN of_IN an_DT exogenous_JJ
          substrate_NN (_( GST-Igα_NNP )_) in_IN an_DT immune-complex_JJ kinase_NN assay_NN ._.
          Kinase_NNP activity_NN was_VBD not_RB detectable_JJ for_IN the_DT K_NNP 430_CD E_NNP mutant_JJ
          of_IN Btk_NNP :_: ER_NNP (_( Fig_NNP 1_CD B_NNP )_) ,_, comparable_JJ to_TO control_VB
          immunoprecipitations_NNS from_IN Btk-deficient_NNP cells_NNS (_( data_NNS not_RB
          shown_VBN )_) ._. In_IN order_NN to_TO determine_VB if_IN Btk_NNP :_: ER_NNP was_VBD active_JJ 
          in_IN vivo_NN ,_, cells_NNS were_VBD treated_VBN with_IN
          vehicle_NN control_NN ,_, 4_CD -_: HT_NNP or_CC anti-μ_JJ ,_, and_CC the_DT phosphorylation_NN
          status_NN of_IN cellular_JJ proteins_NNS and_CC Btk_NNP :_: ER_NNP were_VBD analysed_JJ by_IN
          Western_NNP blotting_VBG (_( Fig_NNP 1_CD C_NNP )_) ._. Upon_IN 4_CD -_: HT_NNP treatment_NN ,_, a_DT
          discrete_JJ set_NN of_IN cellular_JJ proteins_NNS were_VBD inducibly_RB
          phosphorylated_JJ in_IN WT_NNP Btk_NNP :_: ER-expressing_NNP cells_NNS ,_, although_IN
          their_PRP$ phosphorylation_NN levels_NNS and_CC the_DT diversity_NN of_IN
          proteins_NNS phosphorylated_JJ were_VBD reduced_VBN in_IN comparison_NN with_IN
          BCR_NNP cross-linking_JJ ._. As_IN a_DT control_NN ,_, 4_CD -_: HT_NNP treatment_NN did_VBD not_RB
          induce_VB phosphorylation_NN of_IN cellular_JJ proteins_NNS in_IN parental_JJ
          DT_NNP 40_CD cells_NNS without_IN Btk_NNP :_: ER_NNP (_( data_NNS not_RB shown_VBN )_) ._. Btk_NNP :_: ER_NNP itself_PRP
          was_VBD inducibly_RB phosphorylated_JJ upon_IN 4_CD -_: HT_NNP treatment_NN ,_, as_IN
          measured_VBN by_IN anti-phosphotyrosine_JJ blotting_VBG and_CC by_IN a_DT
          phosphospecific_JJ antiserum_NN that_IN recognises_NNS the_DT Y_NNP 223_CD site_NN
          of_IN Btk_NNP autophosphorylation_NN ._. Surprisingly_RB ,_, the_DT
          phosphospecific_JJ antiserum_NN did_VBD not_RB detect_VB Btk_NNP :_: ER_NNP Y_NNP 223_CD
          phosphorylation_NN in_IN response_NN to_TO BCR_NNP cross-linking_JJ ,_,
          suggesting_VBG that_IN the_DT observed_VBN phosphorylation_NN in_IN this_DT case_NN
          is_VBZ largely_RB due_JJ to_TO the_DT Y_NNP 551_CD Lyn_NNP transphosphorylation_NN site_NN ._.
          In_IN cells_NNS expressing_VBG kinase_NN inactive_JJ Btk_NNP :_: ER_NNP ,_,
          phosphorylation_NN of_IN Btk_NNP :_: ER_NNP was_VBD not_RB detected_VBN and_CC cellular_JJ
          substrates_NNS were_VBD not_RB inducibly_RB phosphorylated_JJ in_IN response_NN
          to_TO 4_CD -_: HT_NNP (_( Fig_NNP 1_CD C_NNP )_) ._. These_DT data_NNS suggest_VBP that_IN WT_NNP Btk_NNP :_: ER_NNP ,_, but_CC
          not_RB the_DT kinase_NN inactive_JJ form_NN ,_, can_MD be_VB activated_VBN 
          in_IN vivo_NN by_IN 4_CD -_: HT_NNP ._. The_DT mechanism_NN by_IN
          which_WDT 4_CD -_: HT_NNP activates_NNS Btk_NNP :_: ER_NNP is_VBZ not_RB known_VBN ,_, but_CC may_MD be_VB
          different_JJ to_TO the_DT mechanism_NN of_IN BCR-induced_NNP activation_NN ,_,
          since_IN the_DT two_CD stimuli_NNS induce_VB phosphorylation_NN on_IN different_JJ
          sites_NNS ._.
          The_DT identity_NN of_IN the_DT cellular_JJ proteins_NNS phosphorylated_JJ
          downstream_JJ of_IN Btk_NNP :_: ER_NNP activation_NN (_( 50_CD -_: 79_CD kD_NN range_NN ,_, top_JJ
          panel_NN ,_, Fig_NNP 1_CD C_NNP )_) are_VBP not_RB known_VBN ._. These_DT proteins_NNS are_VBP unlikely_JJ
          to_TO include_VB Lyn_NNP or_CC Syk_NNP ,_, the_DT two_CD PTKs_NNP that_WDT are_VBP primarily_RB
          responsible_JJ for_IN the_DT BCR-induced_NNP tyrosine_NN phosphorylation_NN
          pattern_NN seen_VBN in_IN DT_NNP 40_CD whole_JJ cell_NN lysates_NNS [_NN 14_CD ]_NN ,_, since_IN we_PRP
          were_VBD unable_JJ to_TO detect_VB phosphorylation_NN of_IN Lyn_NNP and_CC Syk_NNP
          following_VBG specific_JJ immunoprecipitations_NNS (_( data_NNS not_RB shown_VBN )_) ._.
          Moreover_RB ,_, the_DT relatively_RB weak_JJ phosphorylation_NN of_IN cellular_JJ
          proteins_NNS induced_VBN by_IN Btk_NNP :_: ER_NNP does_VBZ not_RB suggest_VB that_IN Lyn_NNP
          and_CC /_NN or_CC Syk_NNP are_VBP becoming_VBG activated_VBN (_( Fig_NNP 1_CD C_NNP )_) ._. This_DT is_VBZ
          consistent_JJ with_IN the_DT idea_NN that_IN Lyn_NNP and_CC Syk_NNP are_VBP upstream_RB of_IN
          Btk_NNP activation_NN [_NN 28_CD ]_NN ._.
        
        
          Btk_NNP :_: ER_NNP is_VBZ sufficient_JJ to_TO activate_VBP the_DT PLCγ_NNP 2_CD /_NN calcium_NN
          pathway_NN
          Btk-deficient_NNP B_NNP cells_NNS are_VBP defective_JJ in_IN BCR-induced_NNP
          PLCγ_NNP 2_CD phosphorylation_NN and_CC calcium_NN mobilization_NN [_NN 8_CD ,_, 11_CD ]_NN ._.
          In_IN particular_JJ ,_, the_DT sustained_VBN PLCγ_NNP 2_CD /_NN calcium_NN responses_NNS are_VBP
          impaired_VBN ._. A_DT model_NN has_VBZ been_VBN proposed_VBN in_IN which_WDT Btk_NNP controls_NNS
          calcium_NN influx_NN across_IN the_DT cell_NN membrane_NN by_IN modulating_VBG
          PLCγ_NNP 2_CD activity_NN and_CC thus_RB IP_NNP 3_CD levels_NNS [_NN 6_CD ,_, 29_CD ]_NN ._. Here_RB we_PRP
          tested_VBD whether_IN Btk_NNP :_: ER_NNP activation_NN was_VBD sufficient_JJ to_TO
          activate_VBP the_DT PLCγ_NNP 2_CD /_NN calcium_NN pathway_NN ._.
          Btk-deficient_NNP cells_NNS expressing_VBG either_CC WT_NNP or_CC kinase_NN
          inactive_JJ Btk_NNP :_: ER_NNP were_VBD treated_VBN with_IN 4_CD -_: HT_NNP or_CC anti-μ_JJ and_CC
          PLCγ_NNP 2_CD phosphorylation_NN was_VBD analysed_JJ by_IN Western_NNP blotting_VBG
          (_( Fig_NNP 2_CD A_DT )_) ._. Upon_IN treatment_NN with_IN 4_CD -_: HT_NNP ,_, a_DT sustained_VBN PLCγ_NNP 2_CD
          phosphorylation_NN was_VBD induced_VBN in_IN cells_NNS expressing_VBG WT_NNP Btk_NNP :_: ER_NNP
          that_WDT was_VBD not_RB observed_VBN in_IN cells_NNS expressing_VBG kinase_NN inactive_JJ
          Btk_NNP :_: ER_NNP (_( Fig_NNP 2_CD A_DT )_) ._. As_IN a_DT further_JJ control_NN ,_, 4_CD -_: HT_NNP treatment_NN of_IN
          Btk-deficient_NNP cells_NNS ,_, expressing_VBG Btk_NNP without_IN the_DT ER_NNP
          domain_NN ,_, did_VBD not_RB induce_VB PLCγ_NNP 2_CD phosphorylation_NN (_( Fig_NNP 2_CD B_NNP ,_,
          lanes_NNS 9_CD -_: 11_CD )_) ._. This_DT demonstrates_VBZ that_IN the_DT 4_CD -_: HT_NNP response_NN is_VBZ
          specific_JJ to_TO Btk_NNP :_: ER_NNP ._. Interestingly_RB ,_, the_DT slow_JJ kinetics_NNS of_IN
          PLCγ_NNP 2_CD phosphorylation_NN in_IN response_NN to_TO Btk_NNP :_: ER_NNP differed_VBD
          markedly_RB from_IN the_DT fast_RB ,_, transient_JJ kinetics_NNS in_IN response_NN to_TO
          BCR_NNP cross-linking_JJ (_( compare_VB Fig_NNP 2_CD A_DT ,_, lanes_NNS 6_CD -_: 9_CD ,_, with_IN Fig_NNP
          2_CD B_NNP ,_, lanes_NNS 5_CD -_: 8_CD )_) ._. The_DT slow_JJ Btk_NNP :_: ER_NNP kinetics_NNS are_VBP consistent_JJ
          with_IN data_NNS derived_VBN from_IN Btk-deficient_NNP cells_NNS ,_, in_IN which_WDT
          sustained_VBD BCR-induced_NNP PLCγ_NNP 2_CD phosphorylation_NN ,_, calcium_NN
          mobilization_NN and_CC MAPK_NNP activation_NN are_VBP impaired_VBN ,_, but_CC the_DT
          initial_JJ responses_NNS are_VBP relatively_RB normal_JJ and_CC appear_VB to_TO be_VB
          driven_VBN by_IN Syk_NNP activity_NN (_( reviewed_VBN in_IN reference_NN [_NN 15_CD ]_NN )_) ._.
          Additionally_RB ,_, the_DT sustained_VBN PLCγ_NNP 2_CD phosphorylation_NN induced_VBN
          by_IN Btk_NNP :_: ER_NNP is_VBZ in_IN agreement_NN with_IN the_DT idea_NN that_IN Btk_NNP does_VBZ not_RB
          activate_VBP negative_JJ regulatory_JJ pathways_NNS that_WDT turn_VBP off_IN the_DT
          signal_NN ;_: rather_RB it_PRP is_VBZ Lyn_NNP that_WDT is_VBZ thought_VBN to_TO be_VB largely_RB
          responsible_JJ for_IN this_DT aspect_NN of_IN BCR_NNP signaling_VBG [_NN 15_CD ]_NN ._.
          To_TO determine_VB whether_IN Btk_NNP :_: ER_NNP is_VBZ sufficient_JJ to_TO induce_VB a_DT
          calcium_NN flux_NN ,_, cells_NNS were_VBD loaded_VBN with_IN indo_NN 1_CD and_CC the_DT
          concentration_NN of_IN intracellular_NN free_JJ calcium_NN monitored_VBN by_IN
          FACS_NNP analysis_NN ._. Cells_NNP were_VBD treated_VBN with_IN 4_CD -_: HT_NNP and_CC /_NN or_CC anti-μ_JJ
          as_IN outlined_VBN in_IN Fig_NNP 2_CD C_NNP ._. Strikingly_NNP ,_, upon_IN treatment_NN with_IN
          4_CD -_: HT_NNP ,_, WT_NNP Btk_NNP :_: ER_NNP induced_VBD a_DT rapid_JJ calcium_NN mobilization_NN that_WDT
          was_VBD at_IN a_DT low_JJ level_NN but_CC sustained_VBN (_( Fig_NNP 2_CD C_NNP )_) ._. This_DT pattern_NN
          differed_VBD from_IN that_DT seen_VBN in_IN response_NN to_TO BCR_NNP cross-linking_JJ ,_,
          where_WRB an_DT initial_JJ large_JJ transient_JJ increase_NN in_IN
          intracellular_NN calcium_NN was_VBD followed_VBN by_IN lower_JJR but_CC sustained_VBN
          levels_NNS (_( Fig_NNP 2_CD C_NNP )_) ._. These_DT kinetics_NNS are_VBP similar_JJ to_TO those_DT seen_VBN
          for_IN PLCγ_NNP 2_CD phosphorylation_NN (_( Figs_NNP 2_CD A_DT ,_, B_NNP )_) ,_, again_RB consistent_JJ
          with_IN the_DT idea_NN that_IN Btk_NNP regulates_VBZ the_DT sustained_VBN phase_NN of_IN
          calcium_NN mobilization_NN ._. No_DT additive_JJ or_CC synergistic_JJ effect_NN
          of_IN both_DT 4_CD -_: HT_NNP and_CC anti-μ_JJ was_VBD observed_VBN (_( Fig_NNP 2_CD C_NNP )_) ._. This_DT data_NNS
          indicates_VBZ that_IN Btk_NNP :_: ER_NNP activation_NN alone_RB can_MD induce_VB
          intracellular_NN calcium_NN mobilization_NN and_CC is_VBZ consistent_JJ with_IN
          a_DT previous_JJ study_NN that_WDT showed_VBD cross-linking_JJ of_IN a_DT
          constitutively_RB membrane_NN associated_VBN CD_NNP 16_CD /_NN Btk_NNP chimera_NN to_TO
          induce_VB a_DT calcium_NN flux_NN [_NN 8_CD ]_NN ._.
          In_IN order_NN to_TO evaluate_VB whether_IN Btk_NNP :_: ER-induced_NNP calcium_NN
          mobilization_NN was_VBD due_JJ to_TO calcium_NN release_NN from_IN internal_JJ
          stores_NNS or_CC calcium_NN influx_NN across_IN cell_NN membrane_NN calcium_NN
          release_NN activated_VBN channels_NNS (_( CRAC_NNP )_) ,_, cells_NNS were_VBD pre-treated_JJ
          with_IN EGTA_NNP to_TO chelate_NN extracellular_NN calcium_NN (_( Fig_NNP 2_CD D_NNP ;_: note_NN
          change_NN in_IN scale_NN within_IN Fig_NNP ._. 2_LS Dand_NNP compared_VBD with_IN Fig_NNP 2_CD C_NNP )_) ._.
          In_IN response_NN to_TO anti-μ_JJ treatment_NN of_IN cells_NNS expressing_VBG WT_NNP
          Btk_NNP :_: ER_NNP ,_, the_DT sustained_VBN elevation_NN of_IN intracellular_NN calcium_NN
          was_VBD completely_RB blocked_VBN in_IN the_DT presence_NN of_IN EGTA_NNP ,_, whereas_IN
          the_DT initial_JJ transient_JJ increase_NN was_VBD only_RB slightly_RB
          impaired_VBN ._. Similarly_RB ,_, in_IN response_NN to_TO 4_CD -_: HT_NNP treatment_NN ,_, the_DT
          sustained_VBN increase_NN in_IN intracellular_NN calcium_NN levels_NNS was_VBD
          abrogated_JJ in_IN the_DT absence_NN of_IN extracellular_NN calcium_NN (_( Fig_NNP
          2_CD D_NNP )_) ._. This_DT suggests_VBZ that_IN Btk_NNP :_: ER_NNP may_MD induce_VB calcium_NN release_NN
          from_IN intracellular_NN stores_NNS which_WDT subsequently_RB results_VBZ in_IN
          calcium_NN influx_NN across_IN CRAC_NNP ._. Our_PRP$ data_NNS is_VBZ consistent_JJ with_IN
          that_DT of_IN Fluckiger_NNP 
          et_CC al_NN [_NN 8_CD ]_NN ,_, who_WP proposed_VBD that_IN Btk_NNP
          controls_NNS BCR-induced_NNP calcium_NN signaling_VBG by_IN regulating_VBG
          PLCγ_NNP 2_CD activation_NN ,_, IP_NNP 3_CD levels_NNS and_CC calcium_NN store_NN
          depletion_NN ._.
          Fig_NNP 2_CD Cshows_NNP that_DT kinase_NN inactive_JJ Btk_NNP :_: ER_NNP was_VBD unable_JJ to_TO
          induce_VB a_DT calcium_NN flux_NN ,_, which_WDT ,_, in_IN common_JJ with_IN the_DT PLCγ_NNP 2_CD
          data_NNS (_( Fig_NNP 2_CD A_DT )_) ,_, suggests_VBZ that_DT kinase_NN activity_NN is_VBZ required_VBN
          for_IN Btk_NNP :_: ER_NNP function_NN ._. However_RB ,_, in_IN the_DT context_NN of_IN signaling_VBG
          through_IN the_DT BCR_NNP ,_, we_PRP surprisingly_RB found_VBD that_DT kinase_NN
          inactive_JJ Btk_NNP :_: ER_NNP could_MD reconstitute_NN calcium_NN mobilization_NN
          in_IN these_DT Btk-deficient_NNP cells_NNS (_( Fig_NNP 2_CD C_NNP )_) ._. This_DT was_VBD not_RB an_DT
          artefact_NN of_IN the_DT ER_NNP domain_NN ,_, since_IN non-tagged_JJ kinase_NN
          inactive_JJ Btk_NNP could_MD also_RB restore_VB BCR-induced_NNP calcium_NN flux_NN
          (_( data_NNS not_RB shown_VBN )_) ._. In_IN addition_NN ,_, we_PRP have_VBP found_VBN that_DT kinase_NN
          inactive_JJ Btk_NNP can_MD reconstitute_NN BCR-induced_NNP ERK_NNP MAPK_NNP
          activation_NN ,_, but_CC not_RB PLCγ_NNP 2_CD phosphorylation_NN (_( Tomlinson_NNP ,_,
          Bolen_NNP and_CC Johnston_NNP ,_, unpublished_JJ data_NNS )_) ._. This_DT suggests_VBZ that_IN
          Btk_NNP can_MD function_VB independently_RB of_IN catalytic_JJ activity_NN ,_,
          perhaps_RB as_IN an_DT adapter_NN protein_NN ,_, and_CC that_IN Btk-induced_NNP PLCγ_NNP 2_CD
          phosphorylation_NN is_VBZ not_RB essential_JJ for_IN PLCγ_NNP 2_CD activation_NN ._.
          The_DT mechanism_NN may_MD involve_VB stabilization_NN by_IN Btk_NNP of_IN the_DT
          PLCγ_NNP 2_CD complex_JJ ,_, or_CC '_POS signalosome_NN '_'' [_NN 30_CD ]_NN ,_, in_IN an_DT optimal_NN
          conformation_NN or_CC subcellular_NN location_NN ._. Upon_IN BCR_NNP
          stimulation_NN ,_, Btk_NNP is_VBZ thought_VBN to_TO be_VB recruited_VBN to_TO PLCγ_NNP 2_CD via_IN
          the_DT adapter_NN protein_NN BLNK_NNP ,_, as_IN BLNK_NNP can_MD associate_JJ with_IN the_DT
          SH_NNP 2_CD domains_NNS of_IN both_DT PLCγ_NNP 2_CD [_NN 31_CD ,_, 32_CD ]_NN and_CC Btk_NNP [_NN 33_CD ]_NN ._.
          Membrane_NNP localization_NN of_IN this_DT complex_NN is_VBZ required_VBN for_IN
          PLCγ_NNP 2_CD activation_NN [_NN 32_CD ]_NN ,_, but_CC the_DT mechanism_NN by_IN which_WDT this_DT
          is_VBZ achieved_VBN is_VBZ presently_RB unknown_JJ (_( reviewed_VBN in_IN [_NN 34_CD ]_NN )_) ._. It_PRP
          is_VBZ conceivable_JJ that_IN a_DT Btk_NNP PH_NNP domain-_NN PIP_NNP 3_CD interaction_NN is_VBZ
          important_JJ for_IN membrane_NN localization_NN of_IN the_DT complex_NN ,_, and_CC
          that_IN this_DT function_NN is_VBZ independent_JJ of_IN Btk_NNP kinase_NN activity_NN ._.
          However_RB ,_, it_PRP should_MD be_VB noted_VBN that_DT reconstitution_NN of_IN
          calcium_NN mobilization_NN in_IN Btk-deficient_NNP DT_NNP 40_CD cells_NNS by_IN
          kinase_NN inactive_JJ Btk_NNP was_VBD not_RB observed_VBN in_IN a_DT previous_JJ study_NN
          [_NN 11_CD ]_NN ._. The_DT reason_NN for_IN this_DT discrepancy_NN is_VBZ not_RB clear_JJ ,_, but_CC
          may_MD be_VB due_JJ to_TO the_DT different_JJ mutations_NNS that_WDT were_VBD used_VBN to_TO
          generate_VB kinase_NN inactive_JJ Btk_NNP in_IN the_DT two_CD studies_NNS ._. In_IN the_DT
          present_JJ study_NN we_PRP used_VBD a_DT K_NNP 430_CD E_NNP mutation_NN ;_: K_NNP 430_CD is_VBZ the_DT
          invariant_NN lysine_NN known_VBN to_TO be_VB essential_JJ for_IN enzymatic_JJ
          activity_NN of_IN protein_NN kinases_NNS ._. In_IN the_DT study_NN of_IN Takata_NNP and_CC
          Kurosaki_NNP [_NN 11_CD ]_NN ,_, Btk_NNP was_VBD rendered_VBN catalytically_RB inactive_JJ
          by_IN an_DT R_NN 525_CD Q_NNP mutation_NN ._. Since_IN K_NNP 430_CD is_VBZ located_VBN on_IN the_DT
          smaller_JJR ,_, NH_NNP 
          2_CD -_: terminal_NN lobe_NN of_IN the_DT kinase_NN domain_NN ,_,
          whereas_IN R_NN 525_CD is_VBZ part_NN of_IN the_DT larger_JJR ,_, COOH-terminal_NNP lobe_NN ,_,
          it_PRP is_VBZ possible_JJ that_IN the_DT two_CD mutations_NNS differentially_RB
          affect_VBP the_DT capacity_NN of_IN kinase_NN inactive_JJ Btk_NNP to_TO function_VB as_IN
          an_DT adapter_NN in_IN the_DT activation_NN of_IN PLCγ_NNP 2_CD ._.
        
        
          Btk_NNP :_: ER_NNP is_VBZ sufficient_JJ to_TO activate_VBP ERK_NNP and_CC JNK_NNP MAPK_NNP
          pathways_NNS
          BCR-induced_NNP activation_NN of_IN the_DT ERK_NNP and_CC JNK_NNP MAPK_NNP
          pathways_NNS is_VBZ impaired_VBN in_IN Btk-deficient_NNP DT_NNP 40_CD cells_NNS ,_, but_CC p_NN 38_CD
          MAPK_NNP activation_NN is_VBZ unaffected_JJ [_NN 9_CD ]_NN ._. The_DT precise_JJ role_NN of_IN
          Btk_NNP in_IN the_DT activation_NN of_IN MAPK_NNP pathways_NNS is_VBZ not_RB clear_JJ ,_, but_CC
          these_DT findings_NNS suggest_VBP that_IN Btk_NNP is_VBZ required_VBN for_IN ERK_NNP and_CC
          JNK_NNP activation_NN ._. We_PRP therefore_RB examined_VBD whether_IN Btk_NNP :_: ER_NNP is_VBZ
          sufficient_JJ to_TO induce_VB ERK_NNP and_CC JNK_NNP activity_NN ._.
          In_IN Fig_NNP 3_CD A_DT ,_, Btk-deficient_NNP cells_NNS that_WDT express_VBP either_DT WT_NNP
          or_CC kinase_NN inactive_JJ Btk_NNP :_: ER_NNP were_VBD treated_VBN with_IN 4_CD -_: HT_NNP ,_, or_CC PMA_NNP
          as_IN a_DT positive_JJ control_NN ,_, and_CC ERK_NNP activity_NN was_VBD assessed_VBN by_IN
          immune_JJ complex_JJ kinase_NN assay_NN using_VBG MBP_NNP as_IN an_DT exogenous_JJ
          substrate_NN ._. In_IN response_NN to_TO 4_CD -_: HT_NNP ,_, WT_NNP Btk_NNP :_: ER_NNP ,_, but_CC not_RB the_DT
          kinase_NN inactive_JJ protein_NN ,_, induced_VBD ERK_NNP activity_NN which_WDT
          increased_VBD over_IN the_DT time_NN period_NN examined_VBD (_( Fig_NNP 3_CD A_DT )_) ._. The_DT
          kinetics_NNS were_VBD somewhat_RB different_JJ to_TO those_DT seen_VBN with_IN
          anti-μ_JJ stimulation_NN ,_, where_WRB maximal_NN ERK_NNP activity_NN is_VBZ
          detected_VBN within_IN 5_CD -_: min_NN and_CC is_VBZ sustained_VBN for_IN up_IN to_TO 120_CD -_: min_NN
          [_NN 9_CD ]_NN ._. However_RB Btk_NNP :_: ER_NNP was_VBD clearly_RB able_JJ to_TO induce_VB sustained_VBN
          ERK_NNP activity_NN and_CC this_DT ,_, coupled_VBN with_IN the_DT findings_NNS that_IN in_IN
          Btk-deficient_NNP cells_NNS the_DT sustained_VBN response_NN is_VBZ impaired_VBN [_NN
          9_CD ]_NN ,_, suggest_VBP that_IN Btk_NNP activation_NN may_MD be_VB responsible_JJ for_IN
          the_DT prolonged_JJ ERK_NNP activation_NN normally_RB detected_VBD following_VBG
          BCR_NNP cross-linking_JJ ._. Interestingly_RB ,_, kinase_NN inactive_JJ Btk_NNP :_: ER_NNP
          was_VBD able_JJ to_TO restore_VB ERK_NNP activation_NN in_IN the_DT context_NN of_IN
          anti-μ_JJ stimulation_NN (_( Fig_NNP ._. 3_LS A_DT ,_, lanes_NNS 6_CD and_CC 12_CD )_) ._. This_DT effect_NN
          of_IN kinase_NN inactive_JJ Btk_NNP is_VBZ consistent_JJ with_IN the_DT previous_JJ
          calcium_NN data_NNS (_( Fig_NNP ._. 2_LS C_NNP )_) ,_, and_CC supports_VBZ the_DT idea_NN that_IN Btk_NNP
          can_MD perform_VB a_DT kinase-independent_JJ adapter_NN function_NN ._.
          In_IN Fig_NNP 3_CD B_NNP ,_, JNK_NNP activity_NN was_VBD measured_VBN by_IN Western_NNP
          blotting_VBG whole_JJ cell_NN lysates_NNS with_IN phosphospecific_JJ JNK_NNP
          antiserum_NN ._. This_DT antiserum_NN detects_NNS phosphorylation_NN of_IN JNK_NNP
          at_IN sites_NNS T_NN 183_CD and_CC Y_NNP 185_CD ,_, which_WDT correlates_NNS with_IN JNK_NNP
          activation_NN ._. Addition_NNP of_IN 4_CD -_: HT_NNP to_TO cells_NNS expressing_VBG WT_NNP
          Btk_NNP :_: ER_NNP induced_VBD JNK_NNP phosphorylation_NN to_TO a_DT level_NN that_WDT was_VBD
          similar_JJ to_TO that_DT seen_VBN with_IN anti-μ_JJ treatment_NN (_( Fig_NNP 3_CD B_NNP ,_, lanes_NNS
          2_CD -_: 4_LS )_) or_CC with_IN both_DT 4_CD -_: HT_NNP and_CC anti-μ_JJ (_( Fig_NNP 3_CD B_NNP ,_, lane_NN 5_LS )_) ._.
          However_RB we_PRP did_VBD not_RB detect_VB JNK_NNP phosphorylation_NN following_JJ
          4_CD -_: HT_NNP treatment_NN of_IN cells_NNS expressing_VBG kinase_NN inactive_JJ Btk_NNP :_: ER_NNP
          (_( Fig_NNP 3_CD B_NNP ,_, lanes_NNS 8_CD -_: 9_CD )_) ._. The_DT weak_JJ JNK_NNP phosphorylation_NN in_IN
          cells_NNS expressing_VBG kinase_NN inactive_JJ Btk_NNP :_: ER_NNP ,_, in_IN response_NN to_TO
          anti-μ_JJ or_CC both_DT 4_CD -_: HT_NNP and_CC anti-μ_JJ (_( Fig_NNP 3_CD B_NNP ,_, lanes_NNS 10_CD -_: 11_CD )_) ,_,
          suggests_VBZ a_DT partial_JJ adapter_NN function_NN for_IN Btk_NNP ._. The_DT control_NN
          treatment_NN with_IN PMA_NNP and_CC ionomycin_NN induced_VBD JNK_NNP
          phosphorylation_NN in_IN both_DT cell_NN types_NNS (_( Fig_NNP 3_CD B_NNP ,_, lanes_NNS 6_CD and_CC
          12_CD )_) ._. From_IN these_DT data_NNS we_PRP conclude_VBP that_IN Btk_NNP :_: ER_NNP is_VBZ
          sufficient_JJ to_TO activate_VBP the_DT JNK_NNP pathway_NN in_IN B_NNP cells_NNS ._.
        
        
          Btk_NNP :_: ER_NNP is_VBZ sufficient_JJ to_TO induce_VB DT_NNP 40_CD cell_NN
          apoptosis_NNS
          A_DT major_JJ biological_JJ response_NN of_IN B_NNP cells_NNS to_TO BCR_NNP
          cross-linking_JJ is_VBZ apoptosis_NNS ,_, a_DT function_NN that_WDT is_VBZ strongly_RB
          induced_VBN in_IN DT_NNP 40_CD cells_NNS ._. The_DT mechanism_NN of_IN apoptosis_NNS
          induction_NN is_VBZ not_RB clear_JJ but_CC is_VBZ dependent_JJ on_IN the_DT expression_NN
          of_IN Btk_NNP [_NN 12_CD ,_, 13_CD ]_NN ._. We_PRP therefore_RB tested_VBD whether_IN the_DT
          conditional_JJ form_NN of_IN Btk_NNP alone_RB can_MD induce_VB apoptosis_NNS in_IN
          DT_NNP 40_CD cells_NNS ._.
          In_IN Fig_NNP 3_CD C_NNP ,_, Btk-deficient_NNP cells_NNS expressing_VBG either_CC WT_NNP or_CC
          kinase_NN inactive_JJ Btk_NNP :_: ER_NNP were_VBD treated_VBN with_IN 4_CD -_: HT_NNP and_CC /_NN or_CC
          anti-μ_JJ for_IN 24_CD hours_NNS ._. Apoptosis_NNP was_VBD quantitatively_RB
          measured_VBN by_IN the_DT TUNEL_NNP assay_NN ,_, which_WDT detects_NNS double_RB
          stranded_VBN DNA_NNP breaks_NNS that_WDT are_VBP a_DT hallmark_NN of_IN apoptosis_NNS ._.
          Remarkably_NNP ,_, WT_NNP Btk_NNP :_: ER_NNP induced_VBD apoptosis_NNS to_TO a_DT similar_JJ
          extent_NN to_TO that_DT seen_VBN with_IN BCR_NNP cross-linking_JJ (_( Fig_NNP 3_CD C_NNP )_) ,_,
          despite_IN the_DT fact_NN that_IN PLCγ_NNP 2_CD phosphorylation_NN ,_, calcium_NN
          mobilization_NN ,_, ERK_NNP and_CC JNK_NNP were_VBD relatively_RB weakly_RB
          activated_VBN (_( Figs_NNP 2_CD ,_, 3_CD A_DT ,_, B_NNP )_) ._. However_RB ,_, it_PRP is_VBZ clear_JJ that_IN the_DT
          amplitude_NN and_CC duration_NN of_IN signaling_VBG responses_NNS can_MD control_VB
          differential_NN activation_NN of_IN transcription_NN factors_NNS ._. For_IN
          example_NN ,_, in_IN B_NNP cells_NNS ,_, NF-κB_NNP is_VBZ activated_VBN by_IN a_DT large_JJ ,_,
          transient_JJ calcium_NN flux_NN ,_, whereas_IN NFAT_NNP is_VBZ activated_VBN by_IN a_DT
          low_NN ,_, sustained_VBN calcium_NN plateau_NN [_NN 35_CD ]_NN ._. Thus_RB in_IN DT_NNP 40_CD cells_NNS ,_,
          BCR-induced_NNP apoptosis_NNS may_MD be_VB largely_RB controlled_VBN by_IN
          transcription_NN factors_NNS that_WDT are_VBP themselves_PRP activated_VBN by_IN
          low_JJ ,_, sustained_VBN signals_NNS ,_, which_WDT the_DT BCR_NNP and_CC Btk_NNP :_: ER_NNP can_MD
          activate_VBP equivalently_RB ._.
          A_DT functional_JJ kinase_NN domain_NN was_VBD required_VBN for_IN
          Btk_NNP :_: ER-induced_NNP apoptosis_NNS ,_, as_IN kinase_NN inactive_JJ Btk_NNP :_: ER_NNP
          failed_VBD to_TO induce_VB apoptosis_NNS in_IN response_NN to_TO either_CC 4_CD -_: HT_NNP or_CC
          anti-μ_JJ stimulation_NN (_( Fig_NNP 3_CD C_NNP )_) ._. Interestingly_RB ,_, a_DT low_JJ level_NN
          of_IN apoptosis_NNS was_VBD observed_VBN in_IN response_NN to_TO both_DT 4_CD -_: HT_NNP and_CC
          anti-μ_JJ in_IN cells_NNS expressing_VBG kinase_NN inactive_JJ Btk_NNP :_: ER_NNP (_( Fig_NNP
          3_CD C_NNP )_) ._. This_DT again_RB suggests_VBZ an_DT adapter_NN function_NN for_IN kinase_NN
          inactive_JJ Btk_NNP which_WDT here_RB was_VBD facilitated_JJ by_IN 4_CD -_: HT_NNP ._. The_DT PMA_NNP
          and_CC ionomycin_NN control_NN induced_VBD apoptosis_NNS in_IN both_DT cell_NN
          types_NNS (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          Btk_NNP :_: ER-induced_NNP calcium_NN mobilization_NN ,_, ERK_NNP and_CC JNK_NNP
          activation_NN ,_, and_CC apoptosis_NNS are_VBP dependent_JJ on_IN PLCγ_NNP 2_CD
          Biochemical_NNP analyses_NNS of_IN Btk-deficient_NNP cells_NNS have_VBP
          suggested_VBN that_IN PLCγ_NNP 2_CD is_VBZ a_DT downstream_JJ substrate_NN of_IN Btk_NNP [_NN
          8_CD ,_, 11_CD ]_NN ._. However_RB ,_, the_DT importance_NN of_IN PLCγ_NNP 2_CD in_IN Btk_NNP signaling_VBG
          has_VBZ not_RB been_VBN explored_JJ ._. In_IN particular_JJ ,_, it_PRP is_VBZ not_RB clear_JJ if_IN
          the_DT capacity_NN of_IN Btk_NNP to_TO connect_VB to_TO downstream_JJ signaling_VBG
          pathways_NNS ,_, such_JJ as_IN calcium_NN mobilization_NN ,_, MAPK_NNP activation_NN
          and_CC apoptosis_NNS ,_, is_VBZ mediated_JJ through_IN PLCγ_NNP 2_CD or_CC whether_IN it_PRP
          can_MD occur_VB via_IN other_JJ pathways_NNS ._. In_IN particular_JJ ,_, recent_JJ
          reports_NNS have_VBP suggested_VBN that_IN in_IN addition_NN to_TO PLCγ_NNP 2_CD
          activation_NN ,_, Btk_NNP may_MD function_VB in_IN PI_NNP 3_CD -_: kinase_NN activation_NN ,_,
          cytoskeletal_NN reorganization_NN and_CC DNA_NNP transcription_NN ._. Btk_NNP
          was_VBD shown_VBN to_TO be_VB required_VBN for_IN normal_JJ phosphorylation_NN of_IN a_DT
          novel_NN adapter_NN protein_NN ,_, named_VBD BCAP_NNP ,_, which_WDT couples_NNS
          BCR-activated_NNP PTKs_NNP to_TO PI_NNP 3_CD -_: kinase_NN activation_NN [_NN 17_CD ]_NN ._. Btk_NNP
          may_MD also_RB regulate_VB cytoskeletal_NN reorganization_NN by_IN
          phosphorylating_VBG the_DT Wiskott-_NNP Aldrich_NNP syndrome_NN protein_NN
          (_( WASP_NNP )_) [_NN 18_CD ]_NN ,_, which_WDT plays_VBZ a_DT role_NN in_IN actin_NN polymerization_NN ._.
          Finally_RB ,_, Btk_NNP has_VBZ been_VBN reported_VBN to_TO shuttle_NN to_TO the_DT nucleus_NN
          and_CC may_MD function_VB in_IN transcription_NN by_IN binding_VBG the_DT
          transcription_NN factors_NNS Bright_NNP and_CC BAP-_NNP 135_CD /_NN TFII-I_NNP [_NN 19_CD ,_, 20_CD ,_,
          21_CD ,_, 36_CD ]_NN ._. Thus_RB Btk_NNP may_MD have_VB multiple_JJ targets_NNS ,_, and_CC it_PRP is_VBZ
          not_RB known_VBN which_WDT Btk-induced_NNP signals_NNS are_VBP transmitted_VBN via_IN
          PLCγ_NNP 2_CD ._.
          To_TO address_VB these_DT questions_NNS we_PRP have_VBP expressed_VBN Btk_NNP :_: ER_NNP in_IN
          parental_JJ and_CC PLCγ_NNP 2_CD -_: deficient_NN DT_NNP 40_CD cells_NNS ._. Parental_JJ DT_NNP 40_CD
          cells_NNS were_VBD considered_VBN a_DT better_RB control_NN than_IN the_DT
          Btk-deficient_NNP cells_NNS used_VBN previously_RB (_( Figs_NNP 1_CD -_: 3_LS )_) ,_, as_IN both_DT
          PLCγ_NNP 2_CD -_: deficient_NN and_CC parental_JJ cells_NNS express_VBP endogenous_JJ
          chicken_NN Btk_NNP ._. Thus_RB parental_JJ and_CC PLCγ_NNP 2_CD -_: deficient_NN cells_NNS were_VBD
          transfected_JJ with_IN kinase_NN active_JJ Btk_NNP :_: ER_NNP and_CC stable_JJ clones_NNS
          selected_VBN that_WDT expressed_VBD equivalent_NN levels_NNS of_IN Btk_NNP :_: ER_NNP ,_, as_IN
          measured_VBN by_IN anti-_NN Btk_NNP Western_NNP blotting_VBG of_IN whole_JJ cell_NN
          lysates_NNS (_( Fig_NNP 4_CD A_DT )_) ._.
          To_TO test_VB whether_IN PLCγ_NNP 2_CD is_VBZ required_VBN for_IN Btk_NNP :_: ER-induced_NNP
          calcium_NN mobilization_NN ,_, parental_JJ and_CC PLCγ_NNP 2_CD -_: deficient_NN cells_NNS
          expressing_VBG Btk_NNP :_: ER_NNP were_VBD treated_VBN with_IN 4_CD -_: HT_NNP and_CC /_NN or_CC anti-μ_JJ ,_,
          or_CC ionomycin_NN as_IN a_DT positive_JJ control_NN (_( Fig_NNP 4_CD B_NNP )_) ._. Btk_NNP :_: ER_NNP
          induced_VBD a_DT sustained_VBN calcium_NN signal_NN in_IN parental_JJ cells_NNS but_CC
          not_RB in_IN PLCγ_NNP 2_CD -_: deficient_NN cells_NNS (_( Fig_NNP 4_CD B_NNP )_) ,_, suggesting_VBG that_IN
          Btk_NNP :_: ER_NNP modulates_NNS calcium_NN signaling_VBG by_IN affecting_VBG PLCγ_NNP 2_CD
          activity_NN ._. Consistent_NNP with_IN previous_JJ data_NNS ,_, no_DT calcium_NN
          mobilization_NN was_VBD observed_VBN in_IN PLCγ_NNP 2_CD -_: deficient_NN cells_NNS in_IN
          response_NN to_TO anti-μ_JJ [_NN 37_CD ]_NN ,_, but_CC as_IN expected_VBD a_DT calcium_NN flux_NN
          was_VBD detected_VBN in_IN response_NN to_TO ionomycin_NN ,_, that_WDT bypasses_NNS
          receptor-proximal_JJ signaling_VBG events_NNS (_( Fig_NNP 4_CD B_NNP )_) ._. These_DT data_NNS
          argue_VBP against_IN the_DT possibility_NN that_IN Btk_NNP :_: ER_NNP directly_RB
          controls_VBZ a_DT CRAC_NNP ._. Instead_RB ,_, our_PRP$ data_NNS are_VBP consistent_JJ with_IN
          the_DT model_NN that_IN Btk_NNP :_: ER_NNP indirectly_RB controls_VBZ calcium_NN
          signaling_VBG by_IN regulating_VBG PLCγ_NNP 2_CD activity_NN and_CC thus_RB IP_NNP 3_CD
          levels_NNS and_CC calcium_NN store_NN depletion_NN [_NN 6_CD ,_, 8_CD ,_, 29_CD ]_NN ._.
          In_IN Fig_NNP 5_CD we_PRP have_VBP tested_VBN whether_IN PLCγ_NNP 2_CD is_VBZ required_VBN for_IN
          Btk_NNP :_: ER-induced_NNP ERK_NNP and_CC JNK_NNP activation_NN ,_, and_CC apoptosis_NNS ._. Two_CD
          different_JJ BCR_NNP signaling_VBG pathways_NNS can_MD result_VB in_IN ERK_NNP
          activation_NN in_IN DT_NNP 40_CD cells_NNS ,_, namely_RB a_DT PLCγ_NNP 2_CD -_: independent_JJ
          Grb_NNP 2_CD /_NN Sos_NNP pathway_NN and_CC a_DT PLCγ_NNP 2_CD -_: dependent_JJ pathway_NN that_WDT
          requires_VBZ protein_NN kinase_NN C_NNP [_NN 38_CD ]_NN ._. In_IN Fig_NNP 5_CD Awe_NNP found_VBD that_IN
          Btk_NNP :_: ER_NNP activated_VBN ERK_NNP MAPK_NNP in_IN parental_JJ but_CC not_RB in_IN
          PLCγ_NNP 2_CD -_: deficient_NN cells_NNS (_( lanes_NNS 2_CD and_CC 7_CD )_) ._. Thus_RB Btk_NNP :_: ER_NNP
          appears_VBZ to_TO induce_VB ERK_NNP activation_NN through_IN its_PRP$ capacity_NN to_TO
          activate_VBP PLCγ_NNP 2_CD ,_, and_CC not_RB through_IN a_DT Grb_NNP 2_CD /_NN Sos_NNP pathway_NN ._. In_IN
          response_NN to_TO a_DT 60_CD -_: min_NN treatment_NN with_IN anti-μ_JJ ,_, ERK_NNP
          activation_NN was_VBD detected_VBN in_IN parental_JJ but_CC not_RB in_IN
          PLCγ_NNP 2_CD -_: deficient_NN cells_NNS (_( Fig_NNP 5_CD A_DT ,_, lanes_NNS 3_CD -_: 4_CD and_CC 8_CD -_: 9_CD )_) ,_, but_CC
          control_NN PMA_NNP treatment_NN activated_VBN ERK_NNP in_IN both_DT cell_NN types_NNS
          (_( Fig_NNP 5_CD A_DT ,_, lanes_NNS 5_CD and_CC 10_CD )_) ._. Transient_NNP ERK_NNP activation_NN ,_, 5_CD to_TO
          10_CD -_: min_NN after_IN anti-μ_JJ treatment_NN ,_, can_MD be_VB detected_VBN in_IN
          PLCγ_NNP 2_CD -_: deficient_NN cells_NNS [_NN 13_CD ]_NN ._. These_DT kinetics_NNS are_VBP identical_JJ
          to_TO those_DT observed_VBD in_IN Btk-deficient_NNP cells_NNS [_NN 13_CD ]_NN ._. Together_RB
          with_IN our_PRP$ Btk_NNP :_: ER_NNP data_NNS ,_, this_DT suggests_VBZ that_IN Btk_NNP :_: ER_NNP controls_NNS
          sustained_VBD ERK_NNP activation_NN in_IN B_NNP cells_NNS by_IN regulating_VBG PLCγ_NNP 2_CD
          activity_NN ._.
          The_DT mechanism_NN by_IN which_WDT Btk_NNP connects_VBZ to_TO the_DT JNK_NNP pathway_NN
          is_VBZ not_RB clear_JJ ._. One_CD possibility_NN is_VBZ that_IN Btk_NNP can_MD directly_RB
          activate_VBP components_NNS of_IN the_DT MEKK_NNP 1_CD /_NN SEK_NNP 1_CD /_NN JNK_NNP signaling_VBG
          cascade_NN ._. This_DT pathway_NN is_VBZ controlled_VBN by_IN the_DT small_JJ
          GTP-binding_NNP protein_NN Rac_NNP 1_CD and_CC in_IN DT_NNP 40_CD cells_NNS Rac_NNP 1_CD is_VBZ
          essential_JJ for_IN BCR-induced_NNP JNK_NNP activation_NN [_NN 38_CD ]_NN ._. Thus_RB
          another_DT possibility_NN is_VBZ that_IN Btk_NNP might_MD directly_RB regulate_VB
          Rac_NNP 1_CD activity_NN ._. Alternatively_RB ,_, since_IN the_DT combination_NN of_IN
          protein_NN kinase_NN C_NNP and_CC calcium_NN signaling_VBG is_VBZ sufficient_JJ to_TO
          activate_VBP JNK_NNP [_NN 9_CD ,_, 38_CD ]_NN ,_, Btk_NNP could_MD activate_VBP JNK_NNP indirectly_RB
          through_IN activation_NN of_IN PLCγ_NNP 2_CD ._. In_IN Fig_NNP 5_CD Bwe_NNP show_NN that_IN
          Btk_NNP :_: ER-mediated_NNP JNK_NNP activation_NN is_VBZ dependent_JJ on_IN PLCγ_NNP 2_CD ._.
          Upon_IN 4_CD -_: HT_NNP treatment_NN ,_, phosphorylated_JJ JNK_NNP was_VBD detected_VBN in_IN
          parental_JJ cells_NNS but_CC not_RB in_IN PLCγ_NNP 2_CD -_: deficient_NN cells_NNS (_( Fig_NNP 5_CD B_NNP ,_,
          lanes_NNS 2_CD and_CC 7_CD )_) ._. PLCγ_NNP 2_CD -_: deficient_NN cells_NNS also_RB failed_VBD to_TO
          activate_VBP JNK_NNP in_IN response_NN to_TO anti-μ_JJ treatment_NN or_CC a_DT
          combination_NN of_IN anti-μ_JJ and_CC 4_CD -_: HT_NNP (_( Fig_NNP 5_CD B_NNP ,_, lanes_NNS 3_CD -_: 4_LS )_) ,_,
          whereas_IN parental_JJ cells_NNS did_VBD activate_VBP JNK_NNP following_VBG these_DT
          treatments_NNS (_( Fig_NNP 5_CD B_NNP ,_, lanes_NNS 8_CD -_: 9_CD )_) ._. In_IN response_NN to_TO PMA_NNP and_CC
          ionomycin_NN ,_, activated_VBN JNK_NNP was_VBD detected_VBN in_IN both_DT WT_NNP and_CC
          PLCγ_NNP 2_CD -_: deficient_NN cells_NNS (_( Fig_NNP 5_CD B_NNP ,_, lanes_NNS 5_CD and_CC 10_CD )_) ._. These_DT
          data_NNS are_VBP in_IN agreement_NN with_IN previous_JJ reports_NNS that_WDT document_NN
          the_DT requirement_NN for_IN PLCγ_NNP 2_CD in_IN BCR-induced_NNP JNK_NNP activation_NN [_NN
          38_CD ]_NN ._. Moreover_RB ,_, the_DT data_NNS suggest_VBP that_IN Btk_NNP :_: ER_NNP activates_NNS JNK_NNP
          by_IN a_DT mechanism_NN that_WDT is_VBZ dependent_JJ on_IN PLCγ_NNP 2_CD ,_, rather_RB than_IN
          through_IN activation_NN of_IN more_JJR downstream_JJ elements_NNS of_IN the_DT JNK_NNP
          cascade_NN ._.
          Apoptosis_NNP is_VBZ a_DT major_JJ biological_JJ response_NN of_IN B_NNP cells_NNS to_TO
          BCR_NNP cross-linking_JJ and_CC Btk_NNP is_VBZ clearly_RB necessary_JJ for_IN this_DT
          effect_NN in_IN DT_NNP 40_CD cells_NNS [_NN 12_CD ,_, 13_CD ]_NN ._. Here_RB we_PRP have_VBP shown_VBN Btk_NNP :_: ER_NNP
          activation_NN to_TO be_VB sufficient_JJ to_TO induce_VB apoptosis_NNS in_IN DT_NNP 40_CD
          cells_NNS (_( Fig_NNP 3_LS )_) ._. In_IN Fig_NNP 5_CD Cwe_NNP have_VBP investigated_VBN the_DT
          mechanism_NN by_IN measuring_VBG Btk_NNP :_: ER-induced_NNP apoptosis_NNS in_IN
          parental_JJ and_CC PLCγ_NNP 2_CD -_: deficient_NN cells_NNS ._. Twenty-four_CD hours_NNS
          after_IN 4_CD -_: HT_NNP treatment_NN ,_, apoptosis_NNS was_VBD detected_VBN in_IN WT_NNP but_CC
          not_RB in_IN PLCγ_NNP 2_CD -_: deficient_NN cells_NNS (_( Fig_NNP 5_CD C_NNP )_) ._. The_DT response_NN of_IN
          parental_JJ cells_NNS to_TO 4_CD -_: HT_NNP was_VBD consistently_RB lower_JJR than_IN in_IN
          response_NN to_TO anti-μ_JJ (_( Fig_NNP 5_CD Cand_NNP data_NNS not_RB shown_VBN )_) ._. This_DT is_VBZ in_IN
          contrast_NN to_TO the_DT Btk-deficient_NNP cells_NNS analysed_JJ earlier_RBR (_( Fig_NNP
          3_LS )_) ,_, where_WRB 4_CD -_: HT_NNP and_CC anti-μ_JJ yielded_VBD an_DT equivalent_NN apoptotic_JJ
          response_NN ._. This_DT partially_RB impaired_VBN function_NN of_IN Btk_NNP :_: ER_NNP in_IN
          parental_JJ cells_NNS compared_VBN to_TO Btk-deficient_NNP cells_NNS ,_, in_IN
          eliciting_VBG a_DT biological_JJ response_NN ,_, may_MD be_VB due_JJ to_TO the_DT
          presence_NN of_IN endogenous_JJ chicken_NN Btk_NNP that_WDT could_MD compete_VB
          with_IN Btk_NNP :_: ER_NNP for_IN optimal_NN subcellular_NN location_NN ._. Apoptosis_NNP
          was_VBD not_RB detected_VBN above_IN background_NN levels_NNS in_IN
          PLCγ_NNP 2_CD -_: deficient_NN cells_NNS that_WDT were_VBD treated_VBN with_IN anti-μ_JJ or_CC
          both_DT anti-μ_JJ and_CC 4_CD -_: HT_NNP (_( Fig_NNP 5_CD C_NNP )_) ._. This_DT is_VBZ consistent_JJ with_IN
          reports_NNS that_IN PLCγ_NNP 2_CD is_VBZ necessary_JJ for_IN BCR-induced_NNP apoptosis_NNS
          [_NN 37_CD ]_NN ._. Apoptosis_NNP was_VBD detected_VBN in_IN parental_JJ and_CC
          PLCγ_NNP 2_CD -_: deficient_NN cells_NNS in_IN response_NN to_TO the_DT control_JJ PMA_NNP and_CC
          ionomycin_NN treatment_NN (_( Fig_NNP 5_CD C_NNP )_) ._. These_DT data_NNS suggest_VBP that_IN
          Btk_NNP :_: ER_NNP induces_VBZ apoptosis_NNS in_IN DT_NNP 40_CD B_NNP cells_NNS by_IN a_DT
          PLCγ_NNP 2_CD -_: dependent_JJ mechanism_NN ._.
          In_IN DT_NNP 40_CD B_NNP cells_NNS ,_, apoptosis_NNS induction_NN by_IN Btk_NNP :_: ER_NNP may_MD be_VB
          a_DT consequence_NN of_IN its_PRP$ capacity_NN to_TO activate_VBP JNK_NNP ,_, since_IN in_IN
          these_DT cells_NNS JNK_NNP activation_NN correlates_NNS more_RBR closely_RB with_IN
          apoptosis_NNS than_IN does_VBZ ERK_NNP activation_NN ._. In_IN particular_JJ ,_, we_PRP
          have_VBP found_VBN that_IN Btk-deficient_NNP DT_NNP 40_CD cells_NNS reconstituted_JJ
          with_IN Txk_NNP ,_, an_DT atypical_JJ Tec_NNP family_NN PTK_NNP ,_, fail_VB to_TO undergo_VB
          BCR-induced_NNP JNK_NNP activation_NN (_( Tomlinson_NNP and_CC Johnston_NNP ,_,
          unpublished_JJ data_NNS )_) and_CC apoptosis_NNS [_NN 13_CD ]_NN ,_, but_CC ERK_NNP activation_NN
          is_VBZ relatively_RB normal_JJ [_NN 13_CD ]_NN ._. In_IN contrast_NN to_TO the_DT
          pro-apoptotic_JJ role_NN for_IN Btk_NNP in_IN DT_NNP 40_CD cells_NNS ,_, Btk_NNP appears_VBZ to_TO
          play_VB an_DT anti-apoptotic_JJ role_NN in_IN mature_VBP B_NNP cells_NNS 
          in_IN vivo_NN ._. The_DT mechanism_NN may_MD involve_VB
          Btk-dependent_NNP activation_NN of_IN the_DT transcription_NN factor_NN NF-κ_NNP
          B_NNP [_NN 7_CD ,_, 10_CD ]_NN and_CC subsequent_JJ upregulation_NN of_IN the_DT
          anti-apoptotic_JJ protein_NN Bcl-_NNP X_NNP 
          L_NNP [_NN 39_CD ,_, 40_CD ]_NN ._.
          Previous_JJ studies_NNS have_VBP shown_VBN that_IN DT_NNP 40_CD cells_NNS deficient_NN
          for_IN Btk_NNP and_CC PLCγ_NNP 2_CD have_VBP similar_JJ BCR_NNP signaling_VBG defects_NNS ._.
          Readouts_NNP have_VBP included_VBN calcium_NN mobilization_NN and_CC apoptosis_NNS
          [_NN 11_CD ,_, 37_CD ]_NN ,_, MAPK_NNP activation_NN [_NN 9_CD ,_, 38_CD ]_NN and_CC NF-κB_NNP activation_NN
          [_NN 41_CD ]_NN ._. In_IN addition_NN ,_, mice_NNS deficient_NN for_IN Btk_NNP and_CC PLCγ_NNP 2_CD have_VBP
          similar_JJ defects_NNS in_IN B_NNP cell_NN development_NN and_CC function_NN
          (_( reviewed_VBN in_IN [_NN 30_CD ]_NN )_) ._. These_DT findings_NNS have_VBP lead_VBN to_TO the_DT
          hypothesis_NNS that_IN Btk_NNP and_CC PLCγ_NNP 2_CD are_VBP components_NNS of_IN the_DT same_JJ
          signaling_VBG unit_NN ,_, or_CC signalosome_NN [_NN 30_CD ]_NN ._. However_RB ,_, these_DT
          findings_NNS have_VBP not_RB proved_VBN that_IN Btk_NNP connects_VBZ to_TO the_DT above_JJ
          mentioned_VBN pathways_NNS via_IN PLCγ_NNP 2_CD ._. In_IN the_DT present_JJ study_NN ,_, while_IN
          we_PRP cannot_NN rule_NN out_RP the_DT possibility_NN that_IN Btk_NNP :_: ER_NNP activates_NNS
          PLCγ_NNP 2_CD in_IN combination_NN with_IN other_JJ uncharacterized_JJ pathways_NNS ,_,
          our_PRP$ data_NNS strongly_RB support_VBP the_DT Btk_NNP /_NN PLCγ_NNP 2_CD signalosome_NN model_NN
          by_IN showing_VBG that_IN PLCγ_NNP 2_CD is_VBZ absolutely_RB required_VBN for_IN
          Btk_NNP :_: ER-induced_NNP calcium_NN ,_, MAPK_NNP and_CC apoptosis_NNS responses_NNS ._.
        
      
      
        Conclusions_NNP
        The_DT Btk_NNP mutations_NNS found_VBD in_IN XLA_NNP patients_NNS and_CC the_DT 
        xid_NN mouse_NN show_NN that_IN Btk_NNP is_VBZ required_VBN
        for_IN normal_JJ B_NNP cell_NN development_NN ,_, but_CC the_DT important_JJ pathways_NNS
        activated_VBN by_IN Btk_NNP have_VBP yet_RB to_TO be_VB fully_RB identified_VBN ._. In_IN this_DT
        paper_NN we_PRP show_VBP that_IN a_DT conditional_JJ form_NN of_IN Btk_NNP (_( Btk_NNP :_: ER_NNP )_) is_VBZ
        sufficient_JJ to_TO activate_VBP many_JJ signaling_VBG pathways_NNS downstream_JJ
        of_IN the_DT antigen_NN receptor_NN ,_, including_VBG PLCγ_NNP 2_CD phosphorylation_NN ,_,
        calcium_NN mobilization_NN ,_, apoptosis_NNS and_CC ERK_NNP and_CC JNK_NNP activation_NN ._.
        Our_PRP$ findings_NNS clearly_RB indicate_VBP that_IN all_DT of_IN these_DT
        Btk_NNP :_: ER-mediated_NNP responses_NNS require_VBP PLCγ_NNP 2_CD ._. In_IN future_JJ studies_NNS ,_,
        Btk_NNP :_: ER_NNP may_MD be_VB a_DT useful_JJ tool_NN for_IN the_DT identification_NN of_IN Btk_NNP
        phosphorylation_NN sites_NNS on_IN PLCγ_NNP 2_CD ,_, and_CC for_IN the_DT discovery_NN of_IN
        novel_NN substrates_NNS ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Cells_NNP
          DT_NNP 40_CD cells_NNS were_VBD cultured_JJ in_IN RPMI_NNP 1640_CD supplemented_JJ
          with_IN 10_CD %_NN fetal_JJ calf_NN serum_NN ,_, 1_CD %_NN chicken_NN serum_NN (_( Sigma_NNP )_) ,_,
          penicillin_NN ,_, streptomycin_NN ,_, glutamine_NN ,_, and_CC 50_CD μM_NN
          mercaptoethanol_NN ._. DT_NNP 40_CD cells_NNS rendered_VBD deficient_NN for_IN 
          btk_NN and_CC 
          plcγ_NN 2_CD by_IN homologous_RB recombination_NN
          were_VBD described_VBN previously_RB [_NN 11_CD ,_, 37_CD ]_NN ._.
        
        
          Antibodies_NNP
          Anti-chicken_NNP μ_NN mAb_NN M_NNP 4_CD [_NN 14_CD ]_NN ,_, anti-_NN Btk_NNP antiserum_NN [_NN 42_CD ]_NN
          and_CC anti-_NN Btk_NNP Y_NNP 223_CD phosphospecific_JJ antiserum_NN [_NN 43_CD ]_NN were_VBD as_IN
          described_VBN ._. Anti-phosphotyrosine_NNP mAbs_NNS were_VBD 5_CD H_NNP 1_CD [_NN 42_CD ]_NN and_CC
          4_CD G_NNP 10_CD (_( Upstate_NNP Biotechnology_NNP ,_, NY_NNP )_) ._. Antisera_NNP against_IN PLCγ_NNP 2_CD ,_,
          ERK_NNP 1_CD ,_, ERK_NNP 2_CD and_CC the_DT hormone-binding_JJ domain_NN of_IN the_DT estrogen_NN
          receptor_NN (_( ER_NNP )_) were_VBD from_IN Santa_NNP Cruz_NNP Biotechnology_NNP (_( Santa_NNP
          Cruz_NNP ,_, CA_NNP )_) ,_, and_CC anti-active_JJ JNK_NNP antiserum_NN was_VBD from_IN Promega_NNP
          (_( Madison_NNP ,_, WI_NNP )_) ._.
        
        
          Biochemical_NNP analyses_NNS
          Btk_NNP :_: ER_NNP proteins_NNS were_VBD activated_VBN with_IN 4_CD -_: hydroxytamoxifen_NN
          (_( 4_CD -_: HT_NNP ;_: Research_NNP Biochemicals_NNP International_NNP )_) ._.
          Immunoprecipitations_NNP ,_, immune_JJ complex_JJ protein_NN kinase_NN
          assays_NNS ,_, and_CC immunoblotting_VBG were_VBD as_IN described_VBN previously_RB [_NN
          44_CD ]_NN ._. ERK_NNP MAPK_NNP assays_NNS were_VBD as_IN described_VBN [_NN 26_CD ]_NN ._. For_IN JNK_NNP
          assays_NNS ,_, cells_NNS were_VBD resuspended_JJ in_IN RPMI_NNP 1640_CD supplemented_JJ
          with_IN 2_CD ._. 5_CD %_NN fetal_JJ calf_NN serum_NN ,_, and_CC following_VBG stimulation_NN
          whole_JJ cell_NN lysates_NNS were_VBD analysed_JJ by_IN Western_NNP blotting_VBG with_IN
          anti-active_JJ JNK_NNP antiserum_NN ._.
        
        
          Cloning_NNP and_CC transfection_NN of_IN Btk_NNP :_: ER_NNP
          constructs_NNS
          Cloning_NNP of_IN mouse_NN Btk_NNP was_VBD as_IN described_VBN [_NN 42_CD ]_NN ._.
          Kinase-inactive_NNP (_( K_NNP 430_CD E_NNP )_) Btk_NNP was_VBD generated_VBN by_IN a_DT two-step_JJ
          PCR_NNP mutagenesis_NNS strategy_NN [_NN 42_CD ]_NN ._. To_TO generate_VB Btk_NNP :_: ER_NNP ,_, DNA_NNP
          sequences_NNS encoding_VBG full-length_JJ mouse_NN Btk_NNP were_VBD amplified_VBN
          by_IN PCR_NNP from_IN Btk_NNP cDNA_NN using_VBG the_DT following_JJ primers_NNS :_: 5_CD '_POS -_:
          TAGTAGGGATCCAGGAAGCCATGGCTGCAGTG-_NNP 3_CD '_POS and_CC
          5_CD '_POS -_: TAGTAGGGATCCGCGGATTCTTCATCCATC-_NNP 3_CD '_'' ._. The_DT PCR_NNP product_NN was_VBD
          cloned_VBN into_IN the_DT BamHI_NNP site_NN of_IN pBP_NN 3_CD :_: ER_NNP (_( pBabepuro_NN
          containing_VBG the_DT hormone-binding_JJ domain_NN of_IN the_DT HE_PRP 14_CD allele_NN
          of_IN the_DT human_JJ estrogen_NN receptor_NN )_) [_NN 26_CD ]_NN ._. Btk_NNP :_: ER_NNP constructs_NNS
          were_VBD subcloned_JJ from_IN pBP_NN 3_CD :_: Btk_NNP :_: ER_NNP into_IN the_DT EcoRI_NNP site_NN of_IN
          the_DT pApuroII_NN vector_NN ._. DT_NNP 40_CD cells_NNS were_VBD transfected_JJ with_IN
          pApuroII_NN :_: Btk_NNP :_: ER_NNP by_IN electroporation_NN and_CC stable_JJ clones_NNS
          selected_VBD [_NN 14_CD ]_NN ._.
        
        
          Calcium_NNP flux_NN analyses_NNS
          DT_NNP 40_CD cells_NNS were_VBD labeled_VBN with_IN 1_CD μM_NN indo-_NN 1_CD AM_NNP (_( Molecular_NNP
          Probes_NNP ,_, Eugene_NNP ,_, OR_NNP )_) for_IN 30_CD -_: min_NN at_IN room_NN temperature_NN ._. After_IN
          labeling_VBG ,_, cells_NNS were_VBD washed_VBN and_CC resuspended_JJ in_IN RPMI_NNP 1640_CD
          supplemented_JJ with_IN 1_CD %_NN fetal_JJ calf_NN serum_NN and_CC 20_CD mM_NN Hepes_NNP
          buffer_NN ._. In_IN some_DT experiments_NNS extracellular_NN calcium_NN was_VBD
          chelated_JJ by_IN pre-treating_JJ the_DT cells_NNS with_IN 3_CD mM_NN EGTA_NNP for_IN
          15_CD -_: min_NN ._. Calcium_NNP flux_NN was_VBD measured_VBN using_VBG a_DT FACSVantage_NNP
          (_( Becton_NNP Dickinson_NNP ,_, Mountain_NNP View_NNP ,_, CA_NNP )_) ._.
        
        
          Apoptosis_NNP assay_NN
          DT_NNP 40_CD cells_NNS were_VBD treated_VBN for_IN 24_CD h_NN and_CC flow_NN cytometry_NN
          analyses_NNS of_IN apoptotic_JJ cells_NNS was_VBD performed_VBN using_VBG the_DT TUNEL_NNP
          in_IN situ_NN cell_NN death_NN detection_NN kit_NN (_( Roche_NNP Molecular_NNP
          Biochemicals_NNP )_) ._. Flow_NNP cytometry_NN was_VBD performed_VBN using_VBG a_DT
          FACSCalibur_NNP (_( Becton_NNP Dickinson_NNP )_) and_CC analyzed_VBD using_VBG
          CellQuest_NNP software_NN (_( Becton_NNP Dickinson_NNP )_) ._.
        
      
    
  
